Home

PharmaCyte Biotech, Inc. - Common Stock (PMCB)

0.8900
+0.2400 (36.92%)
NASDAQ · Last Trade: Nov 25th, 8:55 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Get insights into the top gainers and losers of Tuesday's after-hours session.chartmill.com
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · November 25, 2025
PMCB Stock Jumps 25% After Company Sells Stake In Femasysstocktwits.com
PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.
Via Stocktwits · November 25, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 19, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · May 27, 2025
PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q3 2024investorplace.com
PharmaCyte Biotech just reported results for the third quarter of 2024.
Via InvestorPlace · March 19, 2024
PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q2 2024investorplace.com
PharmaCyte Biotech just reported results for the second quarter of 2024.
Via InvestorPlace · December 18, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 11, 2023
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.
Via Benzinga · April 22, 2022
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
  Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...
Via Benzinga · April 19, 2022
PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidatebenzinga.com
PharmaCyte Biotech Inc (NASDAQ: PMCB) updated its activities to lift the FDA's clinical hold on PharmaCyte's treatment for locally advanced, inoperable...
Via Benzinga · February 14, 2022
Stocks That Hit 52-Week Lows On Tuesdaybenzinga.com
  On Tuesday, 386 stocks made new 52-week lows.
Via Benzinga · September 26, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Gainers Epizyme (NASDAQ:EPZM) shares incr...
Via Benzinga · February 1, 2022
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021benzinga.com
  Upgrades For Nektar Therapeutics (NASDAQ:
Via Benzinga · November 8, 2021
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
  Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Via Benzinga · October 27, 2021
64 Biggest Movers From Yesterdaybenzinga.com
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via Benzinga · October 28, 2021
Why Are PharmaCyte Shares Moving Higher On Thursday?benzinga.com
PharmaCyte Biotech Inc (NASDAQ: PMCB) stock is moving higher in reaction to the first test results of the biocompatibility studies of its CypCaps trial product candidate. These...
Via Benzinga · September 16, 2021
60 Biggest Movers From Yesterdaybenzinga.com
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the...
Via Benzinga · October 27, 2021
41 Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic...
Via Benzinga · September 10, 2021
60 Biggest Movers From Fridaybenzinga.com
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...
Via Benzinga · September 13, 2021
Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday?benzinga.com
The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today.  Investors are expecting a major announcement from the company...
Via Benzinga · September 9, 2021
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
  Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff...
Via Benzinga · September 9, 2021
60 Biggest Movers From Yesterdaybenzinga.com
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Via Benzinga · August 24, 2021
35 Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value...
Via Benzinga · August 23, 2021
25 Stocks Moving in Monday's Pre-Market Sessionbenzinga.com
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...
Via Benzinga · August 23, 2021
22 Stocks Moving in Friday's Pre-Market Sessionbenzinga.com
Gainers GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society...
Via Benzinga · August 20, 2021